Devyser advances U.S. clinical strategy with first patient enrolled in Devyser Accept cfDNA study
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
News | October 14, 2022
We are very happy to announce that TÜV SÜD has verified the update of our quality management system to the latest revision – ISO13485:2016! This is the first milestone in our compliance and transition from the previous IVD Directive (IVDD) to the newly adopted IVD Regulation (IVDR).
Devyser today announced the enrollment of the first patient in its Devyser Accept cfDNA clinical...
Read More
Devyser, a pioneer in advanced genetic testing solutions, is pleased to announce that its...
Read More
Devyser today announced the global launch of Devyser Genomic Blood Typing, a next-generation...
Read More
Devyser, a pioneer in advanced genetic testing solutions, proudly announces the global launch of...
Read More